Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72.
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934–59.
Attanoos R, Williams GT. Epithelial and neuroendocrine tumors of the duodenum. Semin Diagn Pathol. 1991;8(3):149–62.
Fitzgerald TL, Dennis SO, Kachare SD, et al. Increasing incidence of duodenal neuroendocrine tumors: incidental discovery of indolent disease? Surgery. 2015;158(2):466–71.
Tashima T, Ryozawa S, Tanisaka Y, et al. Endoscopic resection using an over-the-scope clip for duodenal neuroendocrine tumors. Endosc Int Open. 2021;9(5):E659–66.
Article PubMed PubMed Central Google Scholar
Ogata Y, Hatta W, Masamune A. Endoscopic muscularis dissection with over-the-scope clip: novel resection technique for duodenal neuroendocrine tumors. Dig Endosc. 2024;36(8):955–6.
Makhlouf HR, Burke AP, Sobin LH. Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer. 1999;85(6):1241–9.
Article PubMed CAS Google Scholar
Randle RW, Ahmed S, Newman NA, et al. Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study. J Gastrointest Surg. 2014;18(2):354–62.
Ruff SM, Standring O, Wu G, et al. Ampullary neuroendocrine tumors: insight into a rare histology. Ann Surg Oncol. 2021;28(13):8318–28.
Panzuto F, Ramage J, Pritchard DM, et al. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3. J Neuroendocrinol. 2023;35(8): e13306.
Article PubMed CAS Google Scholar
Bergsland EK, Goldner WS, Benson AB, et al. Neuroendocrine and aderenal tumors version 1. 2023. National Comprehensive Cancer Network clinical practice guidelines in oncology. https://www.nccn.org/professionals/physician_gls/PDF/neuroendocrine.pdf. Accessed 15 Jan 2025.
Massironi S, Campana D, Partelli S, et al. Heterogeneity of duodenal neuroendocrine tumors: an Italian multi-center experience. Ann Surg Oncol. 2018;25(11):3200–6.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.
Article PubMed PubMed Central Google Scholar
Munn Z, Moola S, Lisy K, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147–53.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
Article PubMed CAS Google Scholar
Barker TH, Migliavaca CB, Stein C, et al. Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol. 2021;21(1):189.
Article PubMed PubMed Central Google Scholar
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Article PubMed PubMed Central Google Scholar
Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet. 1991;337(8746):867–72.
Article PubMed CAS Google Scholar
Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315(7121):1533–7.
Article PubMed PubMed Central CAS Google Scholar
Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343: d4002.
Delcore R Jr, Cheung LY, Friesen SR. Characteristics of duodenal wall gastrinomas. Am J Surg. 1990;160(6):621–3 (discussion 623-4).
Burke AP, Sobin LH, Federspiel BH, et al. Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Arch Pathol Lab Med. 1990;114(7):700–4.
Sugg SL, Norton JA, Fraker DL, et al. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg. 1993;218(2):138–44.
Article PubMed PubMed Central CAS Google Scholar
Kisker O, Bastian D, Bartsch D, et al. Localization, malignant potential, and surgical management of gastrinomas. World J Surg. 1998;22(7):651–7 (discussion 657–8).
Article PubMed CAS Google Scholar
Bornstein-Quevedo L, Gamboa-Dominguez A. Carcinoid tumors of the duodenum and ampulla of vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison. Hum Pathol. 2001;32(11):1252–6.
Article PubMed CAS Google Scholar
Witzigmann H, Loracher C, Geissler F, et al. Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy. Langenbecks Arch Surg. 2002;386(7):525–33.
Mullen JT, Wang H, Yao JC, et al. Carcinoid tumors of the duodenum. Surgery. 2005;138(6):971–7 (discussion 977–8).
Bartsch DK, Waldmann J, Fendrich V, et al. Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma. Br J Surg. 2012;99(9):1234–40.
Article PubMed CAS Google Scholar
Min BH, Kim ER, Lee JH, et al. Management strategy for small duodenal carcinoid tumors: does conservative management with close follow-up represent an alternative to endoscopic treatment? Digestion. 2013;87(4):247–53.
Article PubMed CAS Google Scholar
Waisberg J, Joppert-Netto G, Vasconcellos C, et al. Carcinoid tumor of the duodenum: a rare tumor at an unusual site. Case series from a single institution. Arq Gastroenterol. 2013;50(1):3–9.
Kim SH, Park CH, Ki HS, et al. Endoscopic treatment of duodenal neuroendocrine tumors. Clin Endosc. 2013;46(6):656–61.
Article PubMed PubMed Central Google Scholar
Chopin-Laly X, Walter T, Hervieu V, et al. Neuroendocrine neoplasms of the jejunum: a heterogeneous group with distinctive proximal and distal subsets. Virchows Arch. 2013;462(5):489–99.
Kim GH, Kim JI, Jeon SW, et al. Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study. J Gastroenterol Hepatol. 2014;29(2):318–24.
Untch BR, Bonner KP, Roggin KK, et al. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. J Gastrointest Surg. 2014;18(3):457–62 (discussion 462–3).
Comments (0)